Prot #CACZ885M2201: A multicenter, randomized, double-blind, placebo-controlled study of the safety, tolerability and effects on arterial structure and function of ACZ885 in patients with intermittent claudication

Project: Research project

Project Details

StatusFinished
Effective start/end date2/11/1412/31/16

Funding

  • Novartis Pharmaceuticals Corporation (Prot #CACZ885M2201)